Generic Semaglutide Matches Innovator Drug in Phase 3 Indian Diabetes Trial
A multicenter phase 3 trial in India demonstrated that generic semaglutide achieved non-inferior blood sugar reduction and comparable weight loss ...
A multicenter phase 3 trial in India demonstrated that generic semaglutide achieved non-inferior blood sugar reduction and comparable weight loss ...
A scoping review of 253 randomized controlled trials revealed that only 28 percent reported adverse event occurrences following spinal manipulative ...
A phase II trial in stage II to IIIB lung squamous cell carcinoma found that neoadjuvant camrelizumab combined with chemotherapy ...
A multicentre study of 3,309 Chinese nurses identified three distinct work environment tiers that significantly associate with second-victim support and ...
A systematic review indicates that preoperative colonoscopy after stent placement for obstructive colorectal cancer achieved high completion rates, though evidence ...
A randomized clinical trial evaluating the intravenous SARS-CoV-2 protease inhibitor PF-07304814 in hospitalized COVID-19 patients closed prematurely following serious adverse ...
A systematic review and network meta-analysis of nine clinical studies evaluated the efficacy and safety of PD-1 and PD-L1 inhibitors ...
A retrospective real-world study found that full-dose Nefecon was associated with significant reductions in proteinuria and hematuria alongside stable kidney ...
A multicenter open-label trial evaluated oral extended-release cephalexin combined with clavulanate potassium for bacterial respiratory and skin infections.
A prospective multicenter cohort study across 31 hospitals in China found that a novel antimicrobial regimen significantly increased treatment success ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine